Amanote Research
Register
Sign In
MA14.10 QTc Interval-Prolonging Medications in Lung Cancer: Implications for Clinical Trial Eligibility and Routine Clinical Care
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.437
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
D. Gerber
Publisher
Elsevier BV